Drug recall
Platelets Pheresis Leukocytes Reduced
FDA recall event 66700 · Class II · Ogden Medical Center, Inc.
Key facts
| Event ID | 66700 |
|---|---|
| Recall numbers | B-0175-14 |
| Recalling firm | Ogden Medical Center, Inc. |
| Product type | Biologics |
| Products | Platelets Pheresis Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood products, labeled leukoreduced without the assurance they met the criteria for leukoreduced products, were distributed. |
| Initiation date | Oct 11, 2013 |
| Report date | Dec 25, 2013 |
| Termination date | Dec 16, 2013 |
| City | Ogden |
| State | UT |
| Country | United States |
| FEI number | 1771298 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: